Literature DB >> 24127190

Brainstem PML lesion mimicking MS plaque in a natalizumab-treated MS patient.

Carla Tortorella1, Vita Direnzo, Mariangela D'Onghia, Maria Trojano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24127190     DOI： 10.1212/WNL.0b013e3182a84179

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  4 in total

1.  Unusual natalizumab-associated progressive multifocal leukoencephalopathy starting in the brainstem.

Authors:  Joachim Havla; Reinhard Hohlfeld; Tania Kümpfel
Journal:  J Neurol       Date:  2013-11-26       Impact factor: 4.849

2.  Brainstem progressive multifocal leukoencephalopathy.

Authors:  Gautier Breville; Igor J Koralnik; Patrice H Lalive
Journal:  Eur J Neurol       Date:  2020-12-01       Impact factor: 6.089

3.  Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.

Authors:  Roderick P P W M Maas; Annemarie H G Muller-Hansma; Rianne A J Esselink; Jean-Luc Murk; Clemens Warnke; Joep Killestein; Mike P Wattjes
Journal:  J Neurol       Date:  2016-07-11       Impact factor: 4.849

4.  Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity.

Authors:  Divya Sagar; Narendra P Singh; Rashida Ginwala; Xiaofang Huang; Ramila Philip; Mitzi Nagarkatti; Prakash Nagarkatti; Konstantin Neumann; Jürgen Ruland; Allison M Andrews; Servio H Ramirez; Zafar K Khan; Pooja Jain
Journal:  Sci Rep       Date:  2017-06-02       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.